Skip to main content

Table 4 Proportion of patients achieving target serum TSH levels based on post-operative treatment

From: A multicenter, prospective study to observe the initial management of patients with differentiated thyroid cancer in China (DTCC study)

Category

Target serum TSH achieved

Postoperative RAI (N = 982)

635 (64.7)

No postoperative RAI (N = 1031)

601 (58.3)

Total/near total thyroidecotomy (N = 1672)

1055 (63.1)

Lobectomy (N = 202)

110 (54.5)

High risk of recurrence (N = 485)

315 (64.9)

Intermediate risk of recurrence (N = 1528)

921 (60.3)

  1. Values are presented as n (%)
  2. RAI radioactive iodine, TSH thyroid stimulating hormone